Centre Hospitalier Henri Laborit Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2017
NCT03277339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Henri Laborit

Active Ingredients

Drugs in Phase 4 Trials (1)

paroxetine (paxil) (1 trial)

Drugs in Phase 2 Trials (1)

propranolol (inderal) (1 trial)

Drugs in Other Trials (1)

nicotine (nicorette) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3